Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Subpopulations of Vγ9/Vδ 2 T lymphocytes in BD patients and controls

From: Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicity

  Active BD Inactive BD Controls P
CD45RO-CD27+ (%) 7.5 ± 2.25 24 ± 7 28 ± 8 < 0.0001
CD45RO+CD27+ (%) 11 ± 6.44 47 ± 9 49 ± 9 < 0.0001
CD45RO+CD27- (%) 57 ± 13 17.8 ± 9.7 19.2 ± 6.7 < 0.001
CD45RO-CD27- (%) 20 ± 6 8.6 ± 3.8 5.5 ± 5.5 < 0.001
  1. BD, Behçet's disease.